Phytoestrogens, a class of plant-derived compounds that are structural mimics of estrogen, can bind to estrogen receptors, acting as either agonists or antagonists.
| INTRODUCTION
Phytoestrogens are plant-derived small molecules that can act as potential estrogen receptor agonists or antagonists. Some naturally occurring phytoestrogens include coumestans, flavonoids, isoflavonoids, lignans, and stilbenes (Rietjens, Louisse, & Beekmann, 2017) . Several members of this broad group of plant compounds have been shown to act as natural selective estrogen receptor modulators (SERMs), making them potentially attractive agents for the prevention of postmenopausal osteoporosis and cardiovascular disease (Moutsatsou, 2007; Poluzzi et al., 2014; Simons, Gruppen, Bovee, Verbruggen, & Vincken, 2012) . Currently, prescribed synthetic SERMs such as tamoxifen and raloxifene are known to cause a number of undesirable side effects such as hot flashes, strokes, cataracts, and most notably, tamoxifen has been reported to increase the risk of uterine and endometrial cancers (Hershman et al., 2002) . With the need to develop better alternatives to currently prescribed SERMs, many investigators and clinicians have assessed the effectiveness of several phytoestrogens. However, to date, the clinical benefits of phytoestrogen-based SERMs remains to be established.
The interest in consumption of dietary phytoestrogens comes mainly from epidemiological studies that show that the incidence of breast cancer is lower in females from Asian countries, especially China, Japan, Korea, and Indonesia, thus leading to a hypothesis that women whose diets are rich in phytoestrogens have a reduced risk of developing breast cancer (Adlercruetz, 2002) . In support of these findings, the rate of breast cancer incidence significantly increases in Asian women who migrate to the west and start consuming nontraditional diets (Mense, Hei, Ganju, & Bhat, 2008) . Therefore, it is clear that genetic makeup alone is not the reason behind a lower incidence of breast cancer in Asia.
Since the publication of our last review on phytoestrogens (Ososki & Kennelly, 2003) , the total number of review articles on this topic has expanded to more than 800 based upon PubMed. The focus of these reviews has varied from enzymes and pathways modulated by phytoestrogens to the long-standing debate on phytoestrogen risk-benefit analysis in breast cancer survivors especially postmenopausal women (Alipour, Jafari-Adli, & Eskandari, 2015; Archer, 2014; Boucher et al., 2013; Gaowa et al., 2015; Iqra, Avidyuti, Juliet, & Saffron, 2014; Liu, Huang, & Wang, 2012; Satih et al., 2010) . In addition to noting new phytoestrogens that have been reported in the last 7 years, this review discusses biomedical applications of phytoestrogens in relation to breast cancer intervention in estrogen receptor positive and negative breast cancer, chemoprevention, drug delivery systems used to enhance the efficacy of phytoestrogens, and relevant clinical studies that have explored the effect of phytoestrogens. This review will serve as a focused reference for readers who are interested in recent advancements in the field of phytoestrogens specifically in relation to breast pathophysiology.
| CLASSIFICATION OF PHYTOESTROGENS
The discovery of phytoestrogens was serendipitous through a perplexing case of infertility in sheep, and the cause was ultimately determined to be isoflavones from the red clover in the pastures (Bennets, Underwood, & Shier, 1946) . Phytoestrogens are composed of a structurally diverse group of natural products such as lignans, flavonoids, isoflavonoids, coumestans, and stilbenes (Ososki & Kennelly, 2003) . Although these compounds have been reviewed in depth previously (Ososki & Kennelly, 2003) , the focus of this review is on the different classes of phytoestrogens, their dietary sources, and their estrogenic effects, specifically in relation to breast pathophysiology.
| Lignans
Lignans contain two phenylpropanoid units linked via a carbon-carbon single bond, and two well-known lignans are secoisolariciresinol and matairesinol (Ososki & Kennelly, 2003) . Cereal bran, beans, flax seed, nuts, and unrefined grains are some of the important dietary sources of lignans. Certain lignans are known to be metabolized to the estrogenic compounds enterolactone and enterodiol by the action of gut microbial flora (Cornwell, Cohick, & Raskin, 2004) . This gut microbial transformation could explain why some women respond to certain phytoestrogens and others do not. Therefore, it can be difficult to establish an effective dose and bioavailability for such phytoestrogens in different individuals.
| Isoflavonoids
Isoflavonoids are a class of flavonoids that have been studied extensively for their estrogenic effects. One of the well-studied dietary sources of phytoestrogens is soy (Glycine max) that contains two principle isoflavones, daidzein, and genistein. In addition, glycetin, formononetin, and biochanin A are some of the other well-studied dietary phytoestrogens (Preedy, 2012) . Structural similarities between isoflavonoids and estradiol enable isoflavonoids to bind to the estrogen receptor (Bedel, Nachtigall, & Naftolin, 2014; Sefirin et al., 2014) . Although soy is a rich source of isoflavones, other isoflavones have been reported in more than 40 plant species (Ososki & Kennelly, 2003) . Some examples include legumes, such as alfalfa (Medicago sativa), chickpeas (Cicer arietinum), common bean (Phaseolus vulgaris), and red clover (Trifolium pratense). Herbs such as Sophora japonica, Pueraria lobata (kudzu), and Radix pueraria (an ingredient used in traditional Chinese medicine) are rich in daidzein (El-Halawany, Chung, Abdallah, Nishihara, & Hattori, 2010; Hong et al., 2011) .
The estrogenic benefits of isoflavones appear to be a function of an intricate balance between the bioconversion and bioavailability of isoflavones after they are ingested. The isoflavone daidzein is metabolized into equol by a number of enteric bacteria such as Adlercreutzia, Asaccharobacter, Eggerthella, Lactococcus, and Slackia (Rafii, 2015) .
Equol is one of the most bioactive isoflavones, capable of binding to both ERα and ERβ receptors (Kelly, Seidlova-Wuttke, Wuttke, O'Leary, & Norris, 2014; Magee, Allsopp, Samaletdin, & Rowland, 2014) . However, the ability to metabolize daidzein to equol varies from one person to the other, and individuals who are capable of metabolizing daidzein into equol are known as equol producers (Shor, Sathyapalan, Atkin, & Thatcher, 2012) . Studies have shown that equol is stronger than daidzein in inducing the mRNA expression of estrogen-responsive protein PS2 in MCF 7 cells (Sathyamoorthy & Wang, 1997) . The presence of an enteric bacterial population capable of metabolizing isoflavones plays an important role in their bioavailability.
| Coumestans
Coumestans are polycyclic aromatic plant secondary metabolites with a carbon-carbon double bond shared by a coumarin moiety and a benzofuran moiety. Their estrogenic and anticancer effects range from modulating pathways related to cell proliferation, synthesis, and survival including ROS production and DNA damage (Nehybova, Smarda, & Benes, 2014) . Coumesterol is an important member of this class, and is found in alfalfa, clover sprouts, and pinto beans . Trace amounts of coumesterol have also been reported in spinach and Brussel sprouts (Brassica oleracea; Cornwell et al., 2004) 
| Miscellaneous flavonoids
In addition to isoflavonoids and coumestans, another class of estrogenic constituents are prenylflavonoids. The strongest phytoestrogen described is 8-prenylnarigenin, a compound found in hops (Humulus lupulus; Martina, Julie, & Wolfgang, 2008) , and has sparked considerable interest in studies regarding the potential health benefits of beer consumption.
| New phytoestrogens reported for their estrogenic effects in breast cancer
In vivo and in vitro models are both important in the identification of novel phytoestrogens and their mechanism of action. For example, novel erythroidine alkaloids from Erythrina poeppigiana have been reported to be estrogenic in vitro using an MCF-7 ER-dependent cell line assay . This is the first time that an erythroidine alkaloid demonstrated estrogenic activity. Transcriptomic analysis of glyceollins (phytoalexins derived enzymatically from daidzein) attributed the antiproliferative effects of these compounds to modulation of the FOXM1 pathway .
Tanshinone II A, a lipophilic compound isolated from Salvia miltiorrhiza (Danshen), has been analyzed for its potential to bind to ER receptors on vascular endothelial cells (Fang et al., 2011) .
Some phytoestrogens elicit cytotoxic/antiproliferative effects irrespective of the ER receptor status of a given cell line. For example, arctigenin from burdock (Arctium lappa) has been reported to be a phytoestrogen, and has shown anti-invasive and antimigratory effects on both ER-positive (MCF-7) and ER-negative (MDA-MB-231) cell lines (Hsieh et al., 2014) . The antiproliferative effects of arctigenin on MDAMB231 have also been reported (Hsieh et al., 2014; Maxwell, Chun, Lee, Kim, & Nam, 2017) . The mechanisms targeted by phytoestrogens on triple negative cell lines is discussed in a separate section.
Edible plants continue to be an important group to study because many women may ingest these dietary compounds, either as conventional foods or dietary supplements, without considering or understanding their estrogenic potential. A phytoestrogen of interest recently is the coffee constituent trigonelline, reported to be capable of modifying the rate of cell proliferation in vitro, using estrogen receptor positive MCF7 cells (Allred, Yackley, Vanamala, & Allred, 2009 ). An estrogenic diarylheptanoid, (3R)-1,7-diphenyl-(4E,6E)-4,6-heptadien-3-ol, isolated from the rhizomes of Curcuma comosa, showed a protective effect against the deterioration of bone microarchitecture in adult female Sprague-Dawley rats (Tantikanlayaporn et al., 2013) . The phytoestrogen content of foods and dietary supplements continues to be an area of active study due to the important health issues surrounding phytoestrogens.
| PHYTOESTROGENS AND ESTROGEN RECEPTORS
Estrogens are steroid hormones that elicit broad physiological responses and most notably play a key role in regulation of the reproductive cycle in women. Estrogens bind to estrogen receptors, which regulate transcription of target genes by binding to specific sequences called estrogen responsive elements (Welboren, Stunnenberg, Sweep, & Span, 2007) . There are two specific estrogen receptors-ERα and ERβ. The ER ligand binding domains in ERα and ERβ differ by two residues: Met-421(ERα)/Ile-373(ERβ) and Leu-384(ERα)/Met-336(ERβ).
ERα is primarily associated with proliferation, inflammation, and malignancy, whereas ERβ is counter active to these effects, in the sense that it down regulates the action of ERα regulated genes (Christoforous & Jan-Ake, 2011; Treeck, Lattrich, Springwald, & Ortmann, 2010) . The binding of certain phytoestrogens to ERβ might explain how phytoestrogens could be beneficial (Turner, AgatonovicKustrin, & Glass, 2007) . For instance, genistein, apigenin, and daidzein have a greater binding affinity to ERβ (Kuiper et al., 1998) . Structural similarities of phytoestrogens include the presence of a phenolic hydroxyl group, similar to the hydroxyl group in 17β-estradiol. The position of these hydroxyl groups (4, 6, and 7 are more favorable) and their interaction with the ligand binding domains in ERα and ERβ results in activation of the appropriate receptor (Leclercq & Jacquot, 2014) . Although phytoestrogens are capable of binding to ER receptors, their relative binding affinities to a specific type of estrogen receptor varies (Moutsatsou, 2007) , which could account for the differences in activity of the same phytoestrogen in different tissue types.
| DIETARY SOURCES OF PHYTOESTROGENS KNOWN TO AFFECT BREAST PATHOPHYSIOLOGY AND WOMEN'S HEALTH
The US food supplement industry has grown enormously in the past two decades, from $11 million in sales in 1995 to more than $36.7 billion in 2015 (Bradley, 2015; Vatistas & Samuels, 2012) . Flax seed, red clover, soy, and wild yam are some of the main botanicals containing phytoestrogens that are available in the market to treat menopausal symptoms (Borrelli & Ernst, 2010) . Single ingredient supplements with chasteberry, cranberry, evening primrose, garlic, hops, and don quai have been examined for their potential role in reducing the risk of breast cancer in postmenopausal women (Boucher et al., 2013) . Soy, a source of isoflavones, consumed during an individual's early life have shown to offer protective effects against breast cancer, although this study has a small sample size and other statistical concerns (Ziaei & Halaby, 2017) . Black cohosh is one of the most popular dietary supplements for menopausal women. Although there have been reports that this plant contains the phytoestrogen formononetin, additional studies have not been able to verify this (Jiang, Kronenberg, Balick, & Kennelly, 2006; Wuttke et al., 2014) . The bioactivity of black cohosh for the treatment of menopausal hot flashes has been questioned due to the overwhelmingly negative results from clinical trials (Shulman, Banuvar, Fong, & Farnsworth, 2011) . There is no link between consumption of black cohosh and an increased risk of breast cancer (Fritz et al., 2014) . Similarly, clinical evidence to support the use of isoflavonoid-based supplements, such as red clover, in the treatment of hot flashes and menopausal symptoms have not been strong (Lethaby, Marjoribanks, Kronenberg, et al., 2013; Tice et al., 2003) .
There is some evidence that shows soy isoflavones such as daidzein can enhance cancer characteristics in mouse mammary tumor cell lines (Koo et al., 2015; Yang et al., 2015) . In addition, in vivo studies also point to the possibility that soy isolfavones might interfere with the therapeutic effect of tamoxifen . Other studies that have analyzed the use of supplements with multiple phytoestrogens suggest a possible interplay between dietary phytoestrogens and increased tumor cell proliferation in vitro, thereby advising consumers to avoid them, especially while undergoing breast cancer treatment (van Duursen, Smeets, Rijk, Nijmeijer, & van den Berg, 2013) . However, these in vitro models do not completely mimic the conditions in humans because in vivo physiological levels and bioavailability are not accounted for. To date, there is still no strong clinical evidence suggesting phytoestrogens increase breast cancer risk, incidence, or progression (Moreira, Silva, Santos, & Sardao, 2014) .
| ASSAYS FOR PHYTOESTROGENS
Detection of phytoestrogens in plant extracts and in dietary supplements is essential for a better evaluation of their activity, including the quantification of phytoestrogens and the measurement of their estrogenic activity, either as purified compounds or as complex mixtures, such as a botanical extract. These assays also have a number of limitations.
| Assays for quantification of phytoestrogens
Radioimmunoassays have been in use for the detection of daidzein, genistein, and formononetin since 1972 (Cox, Wong, Braden, Trikojus, & Lindner, 1972) . However, quantitative estimation of daidzein in human biological fluids such as serum was reported in 1997 (Lapcik et al., 1997) . They were found to be an efficient alternative to GC-MS or HPLC methods due to their ease, low cost, and their ability to be used in larger epidemiological studies. Analytical methods such as liquid chromatography coupled with mass spectroscopy, UV, IR spectroscopy, capillary electrophoresis, MALDI-TOF, ELISA, and timeresolved fluoro immunoassays are some of the analytical methods used to quantitatively measure phytoestrogens (Garcia-Reyero et al., 2001; Lapcik et al., 1997; Routledge, White, Parker, & Sumpter, 2000; Wang, Prasain, & Barnes, 2002) . However, each of these assays has drawbacks such as the use of radioactive isotopes, being labor intensive, and the difficulty in arriving at absolute quantification. Some of these drawbacks can be overcome by using quantitative affinity assays based on microchip electrophoresis that utilize polyethylene glycol-modified glass microchannel with a short-run time and a small sample volume (Chuang et al., 2006) 
| Bioassays to measure estrogenic activity of phytoestrogens
The classic ligand-binding and ER promoter assays are used to test for estrogenic activity. Ligand-binding assays estimate the binding efficiency of a test compound to receptors ERα or ERβ, but these assays cannot determine if the compound elicits an estrogenic response (Kuiper et al., 1998) . Transactivation assays have been used to detect estrogenic activity. For instance, the estrogenic activity of dietary lignans has been reported using a transgenic estrogen reporter mouse model (Penttinen-Damdimopoulou et al., 2009) . Similarly, Hs578T-ERαLuc and Hs578T-ERβLuc cells have been used to identify and characterize ER subtype selective ligands (Shanle, Hawse, & Xu, 2011) .
High-throughput screening assays based on liquid chromatography mass spectrometry (LC-MS) that can provide enhanced sensitivity, selectivity, and rapid detailed structural information have been developed (Choi & van Breemen, 2008) . Examples of such applications include the use of ER immobilized magnetic particles to eliminate nonspecific binding while studying ER-ligand complexes from botanical extracts such as red clover and hops (Choi & van Breemen, 2008; Rush, Walker, Prehna, Burton, & van Breemen, 2017 ). An extension of such LC-MS-based assays have been reported for chemical and biological standardization of botanical extracts with estrogenic compounds (van Elswijk, Schobel, Lansky, Irth, & van der Greef, 2004) .
These methods are particularly useful to evaluate phytoestrogenbased supplements, to help ensure that the levels of phytoestrogenic compounds in a dietary supplement are standardized and consistent.
Such standardized extracts would then be a reliable source for clinical studies to assess their safety and efficacy, because variation in active ingredients can be precisely monitored. LC-MS-based assays with an ultrafiltration step are extremely useful in screening complex mixtures for ligands and simultaneously estimating their relative binding affinities to specific receptors (Sun et al., 2005) . In addition, methods such as online biochemical detection coupled to mass spectrometry for rapid detection and identification of estrogenic compounds from pomegranate peel extract has also been demonstrated (van Elswijk et al., 2004) . This method is particularly interesting, as it can be used in screening of complex botanical extracts.
Recently, the use of miniature technology has also been explored to test estrogen-like substances, because most of the in vitro assays do not enable simultaneous analysis of bioavailability of an estrogenic compound. This drawback has been addressed by the use of a micro total bioassay made up of polydimethylsiloxane sheets with micro channels that integrate a micro intestine, micro liver, and target cells to be tested onto a microchip (Imura, Sato, & Yoshimura, 2010 ). This assay serves as a multicellular coculture system to study intestinal absorption, hepatic metabolism, and bioactivity of soy isoflavones on MCF7 cells. The micro intestine channels had CaCo2 cells cultured on collagen-coated membranes. A fibronectin pretreated microchannel with HepG2 cells formed the micro liver and a suspension of target cells (MCF7) was cultured on fibronectin-coated micro channels. Unlike conventional bioassays, the micro total bioassay offers benefits such as a reduction in the volume of reagents and samples used. This unique assay system also enables study of sample metabolites with shorter half-life even at negligible volumes. Further, the overall assay time was also reduced to 2 days. Although these assays are more advanced and precise, they need to be further developed and standardized for routine use. Table 1 shows a list of assays used in the detection and quantification of estrogenic activity while highlighting their unique capabilities in comparison with other assays discussed, and their mode of action.
| Enhancing the delivery of phytoestrogens
The low bioavailability of dietary phytoestrogens suggests that for these compounds to be useful physiologically in humans, drug delivery systems may need to be employed to enhance their efficacy. A number of factors may impact a compound's availability, such as the mode of administration, presence of certain functional groups, rate of metabolism, activity of binding proteins, and hydrophobicity play key roles in determining the appropriate drug dosage (Le, 2016) . For instance, genistein exhibits poor water solubility, which in turn results in low oral bioavailability. In order to overcome this issue, a cationic lipid-based nano carrier system targeting the mitochondria has been designed for use in cancer therapy (Pham, Grundmann, & Elbayoumi, 2015) . Commercial cationic copolymers such as Eudragit ® E have been used in a nanoparticle-mediated delivery system to improve oral bioavailability of genistein (Tang et al., 2011) . Several nanoparticle-based systems have been used for topical delivery of genistein (Andrade, de Fatima Reis, Maione-Silva, et al., 2014; Lígia et al., 2014) . and MDA-MB-231 xenograft mouse models, respectively (Kumar et al., 2014; Sharma et al., 2015) . Coencapsulated tamoxifen and quercetin in poly (lactic-co-glycolic acid) have shown to reduce tamoxifen-induced hepatotoxicity. In addition, this nano-formulation proved to induce cell death in vitro (MCF7) and antiangiogenic effects in tumor models in vivo (Jain, Thanki, & Jain, 2013) . In another study, a novel lipid conjugated estrogenic derivative used as an oral adjuvant in mice bearing triple negative breast tumors proved to be more active than current chemotherapeutic drugs, cisplatin, and tamoxifen (Andey et al., 2015) . phytoestrogens from soy and other foods (Iwasaki et al., 2008; Lee et al., 2009) . This is further backed up by ethnobotanical information on the benefits of using phytoestrogen-based herbal preparations and nutraceuticals especially in relation to menopause (Depypere & Comhairea, 2015) . Some studies point out that the reduced risk of breast cancer due to intake of phytoestrogens such as soy isoflavones is evident only in Asians and not in western population (Dong & Qin, 2011) . Also, a higher intake of dietary components such as n-3 polyunsaturated fatty acids, vitamin D, phytoestrogen, fiber, and folate, in addition to lower intake of saturated fat, n-6 polyunsaturated fatty acids, grilled meat, and alcohol, has been suggested to be beneficial in reducing the risk of developing breast cancer (Kotepui, 2016) . Molecular targets of phytoestrogens include cell cycle regulatory proteins and tumor suppressor genes such as cyclin D1, p53, p21, p27, nerve growth factor, and ERα (Chen & Sun, 2012; Lecomte, Lelong, et al., 2017; Sakamoto, Horiguchi, & Oguma, 2010) .
Soy isoflavonoids, especially genistein, have shown antiangiogenic effects, including significant reduction in micro vessel density both in vitro and in vivo (Varinska, Gal, Mirossay, & Mojzis, 2015) . Several in vivo and in vitro studies also explain the role of phytoestrogens in the regulation of proapoptotic and antiapoptotic proteins bcl2 and bax (Rajah, Peine, Du, Serret, & Drews, 2012 Binding of receptors to magnetic micro particles followed by identification of released ligands using LC-MS.
Choi and van Breemen (2008)
Micro total bioassay Polydimethylsiloxane sheets with micro channels that integrate a micro intestine, micro liver, and target cells. Intestinal absorption, hepatic metabolism, and bioactivity of soy isoflavones on MCF7 cells were studied.
Enables study of metabolites with shorter half-life even at negligible volumes. Shorter run time and lower sample and reagent volumes.
Imura et al. (2010)
Nonspecific adsorption assay An ERα and β binding assay that uses auto fluorescent compounds such as coumesterol using fluorescence polarization.
The binding of potent selective ligands determined using fluorescence polarization. A rapid, simple, and homogenous method.
Wang, Li, Zhou, and Huang (2014) HPLC/LC-MS-based high throughput screening assay
Quantitative estimation of isoflavones in dietary supplements using tandem mass spectrometry.
A rapid method to estimate the composition of a single phytoestrogen in multiple dietary supplement samples.
Andres, Hansen, Niemann, Palavinskas, and Lampen (2015) Note. LC-MS = liquid chromatography mass spectrometry.
suggesting the possibility of using phytoestrogens as effective therapeutics against TNBC. These studies range from chemoprotective effects to modulation of key cell survival pathways such as cell cycle, cohesion complex cleavage kinetochore formation, NFκβ, and Ras/ MAPK/AP (Fang, Zhang, Wang, et al., 2016; Hedelin et al., 2008; Li et al., 2008; Pan et al., 2012) . In addition, gene expression profiling studies using microarrays have been reported in various breast cancer subtypes including TNBC. These studies illustrate the ability of genistein and daidzein to have estrogen mimicking activities and alter the expression of genes associated with cell communication, lipid metabolism, signal transduction, fatty acid synthesis, and cell growth (Guo et al., 2016; Satih et al., 2010) . However, the overall risk factor for TNBC in Asia has been reported to be the same as in western countries (Wang et al., 2017) .
Although a number of in vitro studies point to the potential of using phytoestrogens in chemoprevention and/or as adjuvants to chemotherapy regimens in aggressive TNBCs, in vivo studies have not shown such promise. In a TNBC xenograft model, tumor growth was not affected by oral gavage administration of phytoestrogen-rich soy extract (Gallo, Ferlini, Fabrizi, Prislei, & Scambia, 2006) . The use of phytoestrogens for the prevention or treatment of TNBC clearly requires further investigation. Clinical studies are underway to explore the role of phytoestrogens in reducing proliferation of TNBC (Lathrop, 2017) . The results of these studies and the others to come might hold more clues on the exact application of phytoestrogens across a wide demographic.
| Phytoestrogens in hormone replacement therapy
Hormone replacement therapy (HRT) is the substitution of endogenous estrogens with exogenous estrogens, primarily during menopause. Questions about underlying links between HRT in women and an increase in incidence of breast cancer were raised after the release of the Women's Health Initiative study in 1998 (Archer, 2014) . As a consequence, there was an increasing demand for natural alternatives to HRT (Mueller & Jungbauer, 2008; Ross, Paganini-Hill, Wan, & Pike, 2000) . It is at this juncture that phytoestrogens became the focus of the research community, due to their structural similarity to human estradiol and their ability to modulate the estrogen receptor (Sakamoto et al., 2010) . HRT for postmenopausal woman has shown benefits of lowering the risk of fractures, decreasing the incidence of cardiovascular disease, and delaying the onset of Alzheimer's disease. Studies on the benefits of phytoestrogen-rich preparations in perimenopausal women for prevention of atherosclerosis and other climacteric symptoms have been only slightly positive (Kirichenko et al., 2017) . The current knowledge regarding the clinical benefits of phytoestrogens in hormonal replacement therapy is limited (Chen, Lin, & Liu, 2015; Franco et al., 2016) . The use of phytoestrogens in hormone therapy for menopausal symptoms has also not been successful in breast cancer survivors (Alipour et al., 2015 
| Phytoestrogens as SERMs
SERMs are nonsteroidal compounds that serve as ligands for the estrogen receptor while selectively acting as agonists or antagonists.
The presence of two different estrogen receptors-ERα and ERβ-their tissue specific distribution and binding affinities often determines their behavior as an agonist or an antagonist (Jiang et al., 2013) .
Higher ERα levels usually correlate with an increase in cell proliferation, because ERα is associated with regulation of gene expression and proliferation in tissues such as the uterus and breast (Philipp, Maximov, Lee, & Craig, 2013) . ERβ on the other hand mostly acts as a balance and negates the effects of ERα (Paruthiyil et al., 2009 ). However, over 70% of breast cancers are known to express both ERα and ERβ (Charn et al., 2010) . Recently, prenylated isoflavonoids have received attention due to their ability to act like SERMs. Licorice, hops, and sprouts of leguminous seeds are rich sources of prenylated isoflavonoids (Simons et al., 2012) . Diarylheptanoids from Curcuma comosa have been reported for their antiestrogenic activity by downregulating ERα signaling and suppressing estrogen-responsive genes (Thongon et al., 2017) . Daidzein and genistein are isoflavones that exhibit SERM-like behavior. Glabridin, 8-prenylgenistein, kievitone, and phaseollin have shown assay-dependent estrogenicity, that is, they displayed ERα antagonism in a yeast bioassay and they behaved as agonists in human the breast cancer cell lines T47D and MCF7 (Sotoca et al., 2008) . The combinatorial effects of glabidrin with tamoxifen proved to be an effective strategy to reduce incidence of endometrial cancer in an in vitro study using estrogen receptor positive MCF7 cells. A combination of glabridin and tamoxifen caused inhibition of cell growth in Ishikawa and MCF cell lines. This study points out to the potential use of glabridin and tamoxifen in estrogen replacement therapy while negating the side effect of tamoxifen to cause endometrial cancer (Jen, Wei, & Yin, 2015) . Further, apigenin, naringenin, quercetin, biochanin A, hesperitin, silymarin, and fistein have all reported to influence the expression of breast cancer resistance protein (Kaur & Badhan, 2015) . Although available data show that phytoestrogens could be used as an alternative to synthetic SERMs, whether the use of phytoestrogens as SERMs is entirely beneficial remains a question.
In addition, there is still a need for studies that focus on epigenetics and molecular mechanisms in fetal development that could be altered Investigation showed genistein causes a decrease in tumor proliferation and Ki-67 at high expression levels of Ki-67 (Jaskulski et al., 2017) . In contrast, no changes were observed in Ki-67 in a randomized trials investigating the impact of soy on early stage breast cancer patients;
however, this study also found that transcription of genes associated with proliferation were upregulated in woman treated with soy (Shike et al., 2014) . Other studies conducted on the use of soy and flax seed supplements in healthy females, early stage breast cancer patients, and postmenopausal women have shown upregulation in the expression of genes associated with cell proliferation as well (Colli et al., 2012) . In a randomized trial investigating healthy woman classified as high risk for breast cancer, soy consumption failed to show efficacy in prevention and upregulated proliferation markers in premenopausal woman within this study (Khan et al., 2012) . Other randomized studies have shown soy to have no effect on modulating breast density, a known risk factor for breast cancer (Delmanto et al., 2013; Wu et al., 2015) . In healthy postmenopausal women, administration of oral doses of soy isoflavones (900 mg/day) proved to be safe in postmenopausal women (Pop et al., 2008) . The beneficial outcomes of using seaweed as a prebiotic catalyst in favorably altering estrogen and phytoestrogen metabolism in a smaller ethnic group of 15 women has also been reported (Teas et al., 2009 ).
In addition to the studies reported here, long-term projects such as the Korean Hereditary Breast Cancer Study specifically targeting carriers and noncarriers of BRCA mutations might hold some invaluable answers to the long-standing debate on the role of dietary phytoestrogens in lowering the risk of breast cancer and the specific populations that would benefit from the use of phytoestrogens (Kang et al., 2015) . Due to the popularity of phytoestrogen-based supplements, the need for more detailed clinical trials has led to an increase in the number of ongoing studies. A search for ongoing phytoestrogen clinical trials on clinicaltrials.gov showed that results from at least 13 studies are yet to be published.
| CONCLUSIONS
One of the key challenges when working with complex botanical extracts is to achieve consistent quality control per batch to ensure bioactive compounds do not vary greatly, given that environmental factors such as seasonal changes, biotic and abiotic stress can have a significant impact on the expression of phytoestrogenic compounds. Quality assurance issues with botanical dietary supplements include standardizing the concentration and consistency of active constituents and screening for the presence of potential impurities and toxic compounds. Recent advances in the biochemical analysis of phytoestrogens, such as online phytochemical detection coupled to mass spectrometry, use of high-throughput screening methods such as microchips, micro bioassay systems that mimic the human intestinal lumen, and biosensors that help detect phytoestrogens in complex plant extracts can help overcome these challenges (Chuang et al., 2006; Imura et al., 2010; van Elswijk et al., 2004) . However, in the United States, many dietary supplement manufacturers are small companies without the resources to conduct such expensive analyses.
Unless the US Food and Drug Administration requires standardization to a bioactive compound, significant levels of variation will likely continue to be seen in phytoestrogenic supplements such as soy and red clover. Some groups such as the United States Pharmacopeia have developed standards for certain herbal dietary supplements, but US manufacturers are not required to follow these.
Although some in vitro and in vivo studies point to the benefits of phytoestrogens, data available from studies with human subjects are inconclusive as to whether consumption of phytoestrogens is entirely beneficial (Cederroth & Nef, 2009; Poschner et al., 2017; Xiao, Zhang, Tong, & Shi, 2017) . Studies have even pointed out that genistein interferes with the inhibitory effects of tamoxifen on breast cancer cell growth Spagnuolo et al., 2015) . A meta-analysis of prospective studies suggested that high consumption of soy isoflavone decreases risk of breast cancer incidence in Asian populations but not in Western populations (Dong & Qin, 2011) . However, a subsequent meta-analysis indicated that soy consumption associates with protective effects against breast cancer irrespective of nationality, and may reduce recurrence and mortality (Fritz et al., 2013) . The Komen Foundation suggests that breast cancer patients and survivors are not required to completely avoid soy. They can include soy-based products in their diet, whereas the intake of soy supplements is not recommended. A 2017 review highlights human studies and the relationship between dietary phytoestrogens such as isoflavones and breast cancer (Sak, 2017 ).
An important question that then remains is whether phytoestrogens have a protective effect at prolonged exposures in lower doses. Studies like this would help determine the long-term effects of widely marketed phytoestrogen-based dietary supplements and the impact of exposure to dietary phytoestrogens. In addition,
there is a lack of clinical studies on the exposure of a fetus to phytoestrogens. So, the risks associated with phytoestrogen consumption in pregnant women remains unclear (Todaka et al., 2005) . Studies using rodent models have shown that neonatal exposure to genistein caused adverse effects on the female reproductive system (Delclos et al., 2009; Jefferson et al., 2009) . In general, it appears that phytoestrogens, especially those from soy, could have beneficial effects and do not induce endometrial or breast cancer in postmenopausal women (Palacios et al., 2010) . But these studies suffer from lack of a larger sample size and longer exposure times. Therefore, additional randomized clinical trials with a larger sample cohort would help better understand the effects of these phytoestrogens in a pharmacologically relevant dose.
Because an individual's ability to metabolize certain phytoestrogens is dependent on the nature of the individual's gut microbial flora, the interplay between an administered dosage and its bioavailability can induce significant variability in results. Future studies could therefore utilize genetic screening techniques in a personalized medicine approach to understand the genetic predisposition of an individual to metabolize phytoestrogens. The completion of the Cancer Genome Atlas-a collaborative venture of The National Cancer
Institute and National Human Genome Research Institute-is sure to help better understand the molecular signatures of various cancer subtypes. This in turn could be helpful in understanding how the intake of phytoestrogen-containing supplements would affect breast cancer survivors with specific subtypes such as TNBC (Tomczak, Czerwinska, & Wiznerowicz, 2015) . the claim made by a manufacturer with regards to the health benefits of consuming a product/supplement must also be mentioned in the product label (Schneeman, 2011) . Due to the DSHEA, the FDA's ability to regulate botanical supplements is significantly restricted.
Therefore, consumers should be aware of these issues when selecting a phytoestrogen-based supplement. Whether consumption of phytoestrogen-based supplements is purely beneficial is still debatable. So, consumers should discuss their individual risk factors such as family history of breast cancers with their physicians prior to consumption.
Overall, the existing evidence on phytoestrogens is encouraging, as they appear to be safe when consumed as dietary components of foods, even in breast cancer survivors. However, there is not enough clinical evidence at this point of time to support the use of concentrated or purified phytoestrogens in clinical doses as chemopreventive agents. Due to their widespread presence in the human diet, in both conventional foods and dietary supplement products, phytoestrogens remain an important area of study, especially for women's health.
